Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Allergan NYSE:AGN |
63,79 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Jazz Pharmaceuticals NasdaqGS:JAZZ |
11,96 B | 8,10% | 2/6 | 79,55% | -58,02% | 16,37% | UP |
|
Alkermes NasdaqGS:ALKS |
5,55 B | 18,29% | 5/6 | 17,01% | 19,47% | 28,90% | UP |
|
Glanbia ISE:GL9 |
4,21 B | 4,55% | 5/6 | 5,11% | -30,98% | 8,44% | UP |
|
Avadel Pharmaceuticals NasdaqGM:AVDL |
2,12 B | 6,52% | 3/6 | 26,48% | -64,98% | -100,00% | UP |
|
Cosmo Pharmaceuticals N.V. SWX:COPN |
1,48 B | 12,72% | 4/6 | 174,36% | -114,51% | 40,98% | UP |
|
Mallinckrodt OTCPK:MNK |
1,02 B | 0,00% | 3/4 | 0,00% | 0,00% | -100,00% | DOWN |
|
GH Research PLC NasdaqGM:GHRS |
0,98 B | 0,00% | 0/4 | 0,00% | 0,00% | 132,19% | UP |
|
Amryt Pharma NasdaqGM:AMYT |
0,47 B | 24,85% | 0/0 | 0,00% | 0,00% | 0,00% | DOWN |
|
Amarin NasdaqCM:AMRN |
0,30 B | -7,83% | 1/6 | -295,06% | -781,31% | -17,13% | DOWN |
|
Ovoca Bio AIM:OVB |
0,00 B | 0,00% | 2/2 | 0,00% | 0,00% | -100,00% | DOWN |
